$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer 원문보기

Theranostics, v.9 no.3, 2019년, pp.837 - 852  

Kim, Min Woo (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) ,  Jeong, Hwa Yeon (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) ,  Kang, Seong Jae (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) ,  Jeong, In Ho (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) ,  Choi, Moon Jung (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) ,  You, Young Myoung (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) ,  Im, Chan Su (Department of Biomedical Laboratory Science, Yonsei University, Wonju, Republic of Korea) ,  Song, In Ho (Division of RI-Convergence Research, Korea Institute of Radiological and Medical Science, Seoul, Republic of Korea) ,  Lee, Tae Sup (Division of RI-Convergence Research, Korea Institute of Radiological and Medical Science, Seoul, Republic of Korea) ,  Lee, Jin Suk (Department of Anatomy, Yonsei University Wonju Collage of Medicine, Wonju, Republic of Korea) ,  Lee, Aeju (International Research Organizatio) ,  Park, Yong Serk

Abstract AI-Helper 아이콘AI-Helper

Many aptamers have been evaluated for their ability as drug delivery vehicles to target ligands, and a variety of small interfering RNAs (siRNAs) have been tested for their anti-cancer properties. However, since these two types of molecules have similar physicochemical properties, it has so far been...

주제어

참고문헌 (38)

  1. 1 Keefe AD Pai S Ellington A Aptamers as therapeutics Nat Rev Drug Discov 2010 9 537 50 20592747 

  2. 2 Chen K Liu B Yu B Zhong W Lu Y Zhang J Advances in the development of aptamer drug conjugates for targeted drug delivery Wiley Interdiscip Rev Nanomed Nanobiotechnol 2017 9 

  3. 3 Hori SI Herrera A Rossi JJ Zhou J Current advances in aptamers for cancer diagnosis and therapy Cancers (Basel) 2018 10 

  4. 4 Darmostuk M Rimpelova S Gbelcova H Ruml T Current approaches in SELEX: An update to aptamer selection technology Biotechnol Adv 2015 33 1141 61 25708387 

  5. 5 Esposito CL Nuzzo S Kumar SA Rienzo A Lawrence CL Pallini R A combined microRNA-based targeted therapeutic approach to eradicate glioblastoma stem-like cells J Control Release 2016 238 43 57 27448441 

  6. 6 Wang T Gantier MP Xiang D Bean AG Bruce M Zhou SF EpCAM aptamer-mediated survivin silencing sensitized cancer stem cells to doxorubicin in a breast cancer model Theranostics 2015 5 1456 72 26681989 

  7. 7 Catuogno S Rienzo A Di Vito A Esposito CL de Franciscis V Selective delivery of therapeutic single strand antimiRs by aptamer-based conjugates J Control Release 2015 210 147 59 25998051 

  8. 8 Xiang D Shigdar S Qiao G Wang T Kouzani AZ Zhou SF Nucleic acid aptamer-guided cancer therapeutics and diagnostics: the next generation of cancer medicine Theranostics 2015 5 23 42 25553096 

  9. 9 Elbashir SM Lendeckel W Tuschl T RNA interference is mediated by 21- and 22-nucleotide RNAs Genes Dev 2001 15 188 200 11157775 

  10. 10 Titze-de-Almeida R David C Titze-de-Almeida SS The race of 10 synthetic RNAi-based drugs to the pharmaceutical market Pharm Res 2017 34 1339 63 28389707 

  11. 11 Barros SA Gollob JA Safety profile of RNAi nanomedicines Adv Drug Deliv Rev 2012 64 1730 7 22732527 

  12. 12 Hu Y Duan J Zhan Q Wang F Lu X Yang XD Novel MUC1 aptamer selectively delivers cytotoxic agent to cancer cells in vitro PLoS One 2012 7 e31970 22384115 

  13. 13 Volkov AA Kruglova NS Meschaninova MI Venyaminova AG Zenkova MA Vlassov VV Selective protection of nuclease-sensitive sites in siRNA prolongs silencing effect Oligonucleotides 2009 19 191 202 19344210 

  14. 14 Whitehead KA Langer R Anderson DG Knocking down barriers: advances in siRNA delivery Nat Rev Drug Discov 2009 8 129 38 19180106 

  15. 15 Dass CR Choong PF Selective gene delivery for cancer therapy using cationic liposomes: in vivo proof of applicability J Control Release 2006 113 155 63 16764960 

  16. 16 Akbarzadeh A Rezaei-Sadabady R Davaran S Joo SW Zarghami N Hanifehpour Y Liposome: classification, preparation, and applications Nanoscale Res Lett 2013 8 102 23432972 

  17. 17 Kim MW Jeong HY Kang SJ Choi MJ You YM Im CS Cancer-targeted nucleic acid delivery and quantum dot imaging using EGF receptor aptamer-conjugated lipid nanoparticles Sci Rep 2017 7 9474 28842588 

  18. 18 Yip KW Reed JC Bcl-2 family proteins and cancer Oncogene 2008 27 6398 406 18955968 

  19. 19 Kampfer S Windegger M Hochholdinger F Schwaiger W Pestell RG Baier G Protein kinase C isoforms involved in the transcriptional activation of cyclin D1 by transforming Ha-Ras J Biol Chem 2001 276 42834 42 11551901 

  20. 20 Gunaratne A Thai BL Di Guglielmo GM Atypical protein kinase C phosphorylates Par6 and facilitates transforming growth factor beta-induced epithelial-to-mesenchymal transition Mol Cell Biol 2013 33 874 86 23249950 

  21. 21 Paul A Gunewardena S Stecklein SR Saha B Parelkar N Danley M PKClambda/iota signaling promotes triple-negative breast cancer growth and metastasis Cell Death Differ 2014 21 1469 81 24786829 

  22. 22 Ho EA Osooly M Strutt D Masin D Yang Y Yan H Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model J Pharm Sci 2013 102 227 36 23132529 

  23. 23 Ngoune R Peters A von Elverfeldt D Winkler K Putz G Accumulating nanoparticles by EPR: A route of no return J Control Release 2016 238 58 70 27448444 

  24. 24 Koning GA Morselt HW Kamps JA Scherphof GL Uptake and intracellular processing of PEG-liposomes and PEG-immunoliposomes by kupffer cells in vitro 1 * J Liposome Res 2001 11 195 209 19530933 

  25. 25 Chou LY Ming K Chan WC Strategies for the intracellular delivery of nanoparticles Chem Soc Rev 2011 40 233 45 20886124 

  26. 26 Khalil IA Kogure K Akita H Harashima H Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery Pharmacol Rev 2006 58 32 45 16507881 

  27. 27 Zhou X Huang L DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action Biochim Biophys Acta 1994 1189 195 203 8292625 

  28. 28 Pattingre S Tassa A Qu X Garuti R Liang XH Mizushima N Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy Cell 2005 122 927 39 16179260 

  29. 29 Campbell PM Der CJ Oncogenic Ras and its role in tumor cell invasion and metastasis Semin Cancer Biol 2004 14 105 14 15018894 

  30. 30 Laplante M Sabatini DM mTOR signaling in growth control and disease Cell 2012 149 274 93 22500797 

  31. 31 Viloria-Petit AM Wrana JL The TGFbeta-Par6 polarity pathway: linking the Par complex to EMT and breast cancer progression Cell Cycle 2010 9 623 4 20107326 

  32. 32 Goldstein NI Prewett M Zuklys K Rockwell P Mendelsohn J Biological efficacy of a chimeric antibody to the epidermal growth factor receptor in a human tumor xenograft model Clin Cancer Res 1995 1 1311 8 9815926 

  33. 33 Kim K Lee S Ryu S Han D Efficient isolation and elution of cellular proteins using aptamer-mediated protein precipitation assay Biochem Biophys Res Commun 2014 448 114 9 24768638 

  34. 34 Wang J Liu R Liu B Cadmium-containing quantum dots: current perspectives on their application as nanomedicine and toxicity concerns Mini Rev Med Chem 2016 16 905 16 26864550 

  35. 35 Wang Q Chao YM Multifunctional quantum dots and liposome complexes in drug delivery J Biomed Res 2018 32 91 106 28866655 

  36. 36 Xu G Zeng S Zhang B Swihart MT Yong KT Prasad PN New generation cadmium-free quantum dots for biophotonics and nanomedicine Chem Rev 2016 116 12234 327 27657177 

  37. 37 Hong G Dai H In vivo fluorescence imaging in the second near-infrared window using carbon nanotubes Methods Mol Biol 2016 1444 167 81 27283426 

  38. 38 Allen TM Sapra P Moase E Use of the post-insertion method for the formation of ligand-coupled liposomes Cell Mol Biol Lett 2002 7 889 94 12378272 

LOADING...

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

유발과제정보 저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로